FRT vs PULM · rev $1.28B vs $5.4M cap
FRT (FRT) versus Pulmatrix Inc (PULM) — a side-by-side from cached financials, not a winner call.
FRT (FRT) common stock.
Pulmatrix Inc (PULM) is a biotechnology company listed on NASDAQ.
Latest reported FRT revenue for 2025-12-31 was $1.28B. Net income was $411.1M. Revenue was up 6.4% from 2024-12-31 to 2025-12-31. FRT currently screens at market cap $0.
PULM does not have a complete income-statement cache yet.
FRT currently screens at market cap $0. PULM currently screens at market cap $5.4M.
Not investment advice. Open the FRT and PULM stock pages for the full models.
Not investment advice.